TVTX Travere Therapeutics, Inc. Loading...

From WDAY earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
20:30
Aug 27 ◎
Ian Wu President and CFO, Workday, Inc. WDAY Q2 FY27 call
Travere is the global commercialization and development partner for Everest's lead asset, and is credited with deep nephrology expertise and prior FDA approvals, strengthening its pipeline beyond its current assets.
TVTX
HIGH

About TVTX Analyst Coverage

Buzzberg tracks TVTX (Travere Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Past 7 days: 1 watch. Latest voices: Ian Wu.